Enovis Corp (ENOV)

$31.19 -0.21 (-0.67%)
Market Cap 1.79B
Revenue (ttm) 2.11B
Net Income (ttm) -825.49M
EPS (ttm) N/A
PE Ratio 9.71
Forward PE 10.28
Profit Margin -39.17%
Debt to Equity Ratio 0.54
Volume 903,600
Avg Vol 1,276,228
Day's Range N/A - N/A
Shares Out 57.16M
Stochastic %K 43%
Beta 1.68
Analysts Strong Sell
Price Target $52.40

Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic sho...

Industry: Medical Devices
Sector: Healthcare
Phone: 302 252 9160
Address:
2711 Centerville Road, Suite 400, Wilmington, United States
NVDAMillionaire
NVDAMillionaire Sep. 4 at 10:24 AM
$ENOV Great piece that accurately captures ENOV's current position. So if you want to refresh your understanding of ENOV or learn about ENOV for the first time, this is essential reading. https://beyondspx.com/quote/ENOV/enov-forging-a-medtech-future-growth-margins-and-innovation-post-transformation#analysis
0 · Reply
ZacksResearch
ZacksResearch Sep. 2 at 11:52 PM
Tired of the “Magnificent Seven”? Zacks highlights small & mid-cap stocks trading 50%+ below target with “Buy” ratings: $ENOV $NEXN $ROOT $IAS $ARQT Big upside potential 👀 #StocksToBuy #ZacksRank #Investing https://www.zacks.com/featured-articles/101/best-stocks-to-buy-now
0 · Reply
QuantumFinanceCapital
QuantumFinanceCapital Aug. 23 at 1:26 PM
$ENOV Enovis Corporation is facing medical device adoption challenges and acquisition integration
0 · Reply
StockHunter75
StockHunter75 Aug. 22 at 2:48 PM
$ENOV going to run to 35+ load up
0 · Reply
StockHunter75
StockHunter75 Aug. 22 at 2:47 PM
$ENOV Bullish.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 9:30 PM
Canaccord Genuity updates rating for Enovis ( $ENOV ) to Buy, target set at 70 → 58.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 6:36 PM
UBS has updated their rating for Enovis ( $ENOV ) to Buy with a price target of 57.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 3:19 PM
Wells Fargo updates rating for Enovis ( $ENOV ) to Overweight, target set at 48 → 41.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 10:00 AM
Needham updates rating for Enovis ( $ENOV ) to Buy, target set at 57 → 49.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 7 at 10:36 AM
$ENOV Enovis reports Q2 adjusted EPS 79c, consensus 72c -- Q2 revenue $565M, consensus $554.62M. -- Raises FY25 adjusted EPS view to $3.05-$3.20 from $2.95-$3.10, consensus $3.04. -- Raises FY25 revenue view to $2.245B-2.275B, versus prior expectations of $2.22B-2.25B, consensus $2.24B.
0 · Reply
Latest News on ENOV
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Sep 8, 2025, 4:05 PM EDT - 1 day ago

Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Enovis: Healthy Recon Trends Vs. Market Apathy

Aug 27, 2025, 8:24 AM EDT - 14 days ago

Enovis: Healthy Recon Trends Vs. Market Apathy

Enovis to Participate in Upcoming Investor Conferences

Aug 8, 2025, 9:00 AM EDT - 4 weeks ago

Enovis to Participate in Upcoming Investor Conferences

Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:25 AM EDT - 4 weeks ago

Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript

Enovis Announces Second Quarter 2025 Results

Aug 7, 2025, 6:00 AM EDT - 4 weeks ago

Enovis Announces Second Quarter 2025 Results

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

Jul 8, 2025, 4:05 PM EDT - 2 months ago

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor

May 26, 2025, 10:46 AM EDT - 3 months ago

Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor

Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript

May 11, 2025, 1:46 AM EDT - 4 months ago

Enovis Corporation (ENOV) Q1 2025 Earnings Call Transcript

Enovis Announces First Quarter 2025 Results

May 8, 2025, 6:00 AM EDT - 4 months ago

Enovis Announces First Quarter 2025 Results

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Apr 17, 2025, 7:00 AM EDT - 5 months ago

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Apr 2, 2025, 6:30 AM EDT - 5 months ago

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Mar 25, 2025, 8:00 AM EDT - 6 months ago

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Enovis Continues To Languish Despite Decent Financial Results

Feb 28, 2025, 8:23 AM EST - 6 months ago

Enovis Continues To Languish Despite Decent Financial Results

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 12:53 PM EST - 6 months ago

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Enovis Announces Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 6:01 AM EST - 7 months ago

Enovis Announces Fourth Quarter and Full Year 2024 Results

Enovis Announces Planned CEO Succession Process

Feb 26, 2025, 6:00 AM EST - 7 months ago

Enovis Announces Planned CEO Succession Process

Enovis™ Announces Leadership Change to International Surgical Business

Jan 17, 2025, 6:00 AM EST - 8 months ago

Enovis™ Announces Leadership Change to International Surgical Business

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Jan 7, 2025, 6:19 PM EST - 8 months ago

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:15 PM EST - 8 months ago

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Enovis Corporation: Reasonably Valued With Caveats

Nov 22, 2024, 12:17 PM EST - 10 months ago

Enovis Corporation: Reasonably Valued With Caveats

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 12:50 PM EST - 10 months ago

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Enovis Announces Third Quarter 2024 Results

Nov 6, 2024, 6:00 AM EST - 11 months ago

Enovis Announces Third Quarter 2024 Results

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Oct 10, 2024, 7:00 AM EDT - 11 months ago

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says

Oct 3, 2024, 3:39 PM EDT - 1 year ago

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Sep 9, 2024, 3:50 PM EDT - 1 year ago

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

Aug 20, 2024, 8:00 AM EDT - 1 year ago

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Aug 19, 2024, 8:00 AM EDT - 1 year ago

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Enovis Announces Second Quarter 2024 Results

Aug 7, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Second Quarter 2024 Results

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Jul 25, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

Jul 16, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

Enovis Languishing Despite Respectable Performance

Jul 15, 2024, 12:58 AM EDT - 1 year ago

Enovis Languishing Despite Respectable Performance

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

Jul 12, 2024, 8:00 AM EDT - 1 year ago

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

Top 3 Health Care Stocks That Could Blast Off In June

Jun 21, 2024, 8:22 AM EDT - 1 year ago

Top 3 Health Care Stocks That Could Blast Off In June

PEN RGEN

Enovis Corporation (ENOV) Q1 2024 Earnings Call Transcript

May 2, 2024, 2:24 PM EDT - 1 year ago

Enovis Corporation (ENOV) Q1 2024 Earnings Call Transcript

Enovis Announces First Quarter 2024 Results

May 2, 2024, 6:00 AM EDT - 1 year ago

Enovis Announces First Quarter 2024 Results

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Apr 17, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 12:14 PM EST - 1 year ago

Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript

Enovis Announces Fourth Quarter and Full Year 2023 Results

Feb 22, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Fourth Quarter and Full Year 2023 Results

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Feb 12, 2024, 11:30 AM EST - 1 year ago

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Feb 7, 2024, 4:15 PM EST - 1 year ago

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Jan 26, 2024, 6:00 AM EST - 1 year ago

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Jan 25, 2024, 8:30 AM EST - 1 year ago

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Enovis Completes Acquisition of LimaCorporate S.p.A

Jan 3, 2024, 6:00 AM EST - 1 year ago

Enovis Completes Acquisition of LimaCorporate S.p.A

Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 28, 2023, 5:00 AM EST - 1 year ago

Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Enovis Announces Business Segment Leadership Transition Plan

Dec 5, 2023, 6:00 AM EST - 1 year ago

Enovis Announces Business Segment Leadership Transition Plan

Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference

Nov 16, 2023, 4:15 PM EST - 1 year ago

Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference

Enovis Corporation (ENOV) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 11:32 AM EST - 2 years ago

Enovis Corporation (ENOV) Q3 2023 Earnings Call Transcript

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

Nov 7, 2023, 6:00 AM EST - 2 years ago

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028

Oct 20, 2023, 6:00 AM EDT - 2 years ago

ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028

Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023

Oct 19, 2023, 6:58 AM EDT - 2 years ago

Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023

NVDAMillionaire
NVDAMillionaire Sep. 4 at 10:24 AM
$ENOV Great piece that accurately captures ENOV's current position. So if you want to refresh your understanding of ENOV or learn about ENOV for the first time, this is essential reading. https://beyondspx.com/quote/ENOV/enov-forging-a-medtech-future-growth-margins-and-innovation-post-transformation#analysis
0 · Reply
ZacksResearch
ZacksResearch Sep. 2 at 11:52 PM
Tired of the “Magnificent Seven”? Zacks highlights small & mid-cap stocks trading 50%+ below target with “Buy” ratings: $ENOV $NEXN $ROOT $IAS $ARQT Big upside potential 👀 #StocksToBuy #ZacksRank #Investing https://www.zacks.com/featured-articles/101/best-stocks-to-buy-now
0 · Reply
QuantumFinanceCapital
QuantumFinanceCapital Aug. 23 at 1:26 PM
$ENOV Enovis Corporation is facing medical device adoption challenges and acquisition integration
0 · Reply
StockHunter75
StockHunter75 Aug. 22 at 2:48 PM
$ENOV going to run to 35+ load up
0 · Reply
StockHunter75
StockHunter75 Aug. 22 at 2:47 PM
$ENOV Bullish.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 9:30 PM
Canaccord Genuity updates rating for Enovis ( $ENOV ) to Buy, target set at 70 → 58.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 6:36 PM
UBS has updated their rating for Enovis ( $ENOV ) to Buy with a price target of 57.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 3:19 PM
Wells Fargo updates rating for Enovis ( $ENOV ) to Overweight, target set at 48 → 41.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 10:00 AM
Needham updates rating for Enovis ( $ENOV ) to Buy, target set at 57 → 49.
0 · Reply
DonCorleone77
DonCorleone77 Aug. 7 at 10:36 AM
$ENOV Enovis reports Q2 adjusted EPS 79c, consensus 72c -- Q2 revenue $565M, consensus $554.62M. -- Raises FY25 adjusted EPS view to $3.05-$3.20 from $2.95-$3.10, consensus $3.04. -- Raises FY25 revenue view to $2.245B-2.275B, versus prior expectations of $2.22B-2.25B, consensus $2.24B.
0 · Reply
jcmission
jcmission Jul. 21 at 2:06 PM
$ENOV let me add more
1 · Reply
StockHunter75
StockHunter75 Jul. 18 at 6:24 PM
$ENOV stopped out, glta.
0 · Reply
jcmission
jcmission Jul. 18 at 6:12 PM
$ENOV bought at 28 Take us to the ER
0 · Reply
StockHunter75
StockHunter75 Jul. 18 at 2:04 PM
$ENOV bought the dip.
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 17 at 8:01 PM
RECAP 7/17 +Pos Comments: $FAST + Josh Brown RECAP 7/17 -Neg Comments: $ENOV - Jehosephat $CLSD - Citizens JMP $WFC - Phillip Securities Live Breaking trading news www.openoutcrier.com
0 · Reply
DonCorleone77
DonCorleone77 Jul. 17 at 1:49 PM
$ENOV You can look up Jehoshaphat (short-seller): Jehoshaphat announces new short position in Enovis
1 · Reply
StockHunter75
StockHunter75 Jul. 16 at 7:22 PM
$ENOV Bullish 🐂
0 · Reply
jcmission
jcmission Jul. 16 at 4:01 PM
$ENOV Bought at 30
0 · Reply
StockHunter75
StockHunter75 Jul. 16 at 2:24 PM
$ENOV it's bottomed out and it's a perfect time to add a long position.
0 · Reply
StockHunter75
StockHunter75 Jul. 16 at 2:09 PM
$ENOV buying more.
0 · Reply
StockHunter75
StockHunter75 Jul. 15 at 2:29 PM
$ENOV no worries shorts will have to cover or burn.
0 · Reply
StockHunter75
StockHunter75 Jul. 15 at 1:39 PM
$ENOV buying the dip.
0 · Reply